Westfield Capital Management
ELV icon

Westfield Capital Management’s Elevance Health ELV Stock Holding History

Westfield Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,551
Closed -$807K – 252
2024
Q3 		$807K Buy
1,551
+321
+26% +$171K ﹤0.01% 229
2024
Q2 		$666K Buy
+1,230
New +$650K ﹤0.01% 234

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Westfield Capital Management's ELV Position: Q4 2024 in Review

Westfield Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,551 shares — an estimated $807K sold.

Westfield Capital Management first reported a position in ELV in Q2 2024 and held it in 2 quarters. The position peaked at $807K in Q3 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Westfield Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Westfield Capital Management sold 1,551 Elevance Health shares in Q4 2024, an estimated $807K.
  • Westfield Capital Management first reported a position in Elevance Health in Q2 2024 and held it in 2 quarters.
  • Westfield Capital Management's Elevance Health position peaked at $807K in Q3 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Westfield Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.